HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency.

Abstract
The elastase-like activities in whole cell extracts of neutrophilic polymorphonuclear leukocytes of 10 emphysematous patients with alpha 1-antitrypsin deficiency (PiZ) and of 7 subjects with alpha 1-antitrypsin deficiency (PiZ or PiSZ) without emphysema were the same as the activities of healthy nondeficient subjects (PiMM) matched according to age, sex, and smoking history. In 16 emphysematous patients without alpha 1-antitrypsin deficiency (PiMM) however, the leukocyte elastase-like activity tended to be higher than that of normal control subjects. We concluded that in persons with alpha 1-antitrypsin deficiency, the leukocyte elastase-like activity is not a deciding factor in the development of emphysema. In persons without alpha 1-antitrypsin deficiency, however, the leukocyte elastase-like activity may be a contributing factor in the development of this disease. Variations in specific anti-leukocyte-elastase-like activity of alpha 1-antitrypsin, which might play a role in the pathogenesis of emphysema, were not found.
AuthorsJ A Kramps, W Bakker, J H Dijkman
JournalThe American review of respiratory disease (Am Rev Respir Dis) Vol. 121 Issue 2 Pg. 253-61 (Feb 1980) ISSN: 0003-0805 [Print] United States
PMID6965829 (Publication Type: Journal Article)
Chemical References
  • alpha 1-Antitrypsin
  • Pancreatic Elastase
Topics
  • Adult
  • Age Factors
  • Aged
  • Female
  • Humans
  • Leukocytes (enzymology)
  • Male
  • Middle Aged
  • Neutrophils (enzymology)
  • Pancreatic Elastase (metabolism, physiology)
  • Phenotype
  • Pulmonary Emphysema (enzymology, etiology, physiopathology)
  • Sex Factors
  • Smoking (complications)
  • alpha 1-Antitrypsin (metabolism)
  • alpha 1-Antitrypsin Deficiency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: